tiprankstipranks
NeuroPace price target lowered to $13 from $15 at Wells Fargo
The Fly

NeuroPace price target lowered to $13 from $15 at Wells Fargo

Wells Fargo lowered the firm’s price target on NeuroPace (NPCE) to $13 from $15 and keeps an Overweight rating on the shares. The firm notes the company reported Q3 revenues well ahead of Wells’ and consensus estimates. Management increased revenue guidance for the year again, but held the line on OpEx andGM guidance, the firm adds.

Don't Miss our Black Friday Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App